Myomo (MYO) Enterprise Value Growth (1y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 27.13% |
| Sep 30, 2025 | -79.40% |
| Jun 30, 2025 | -76.54% |
| Mar 31, 2025 | -123.29% |
| Dec 31, 2024 | -184.69% |
| Sep 30, 2024 | 37.07% |
| Jun 30, 2024 | 24.57% |
| Mar 31, 2024 | -18.30% |
| Dec 31, 2023 | -65.84% |
| Sep 30, 2023 | -50.28% |
| Jun 30, 2023 | -16.32% |
| Mar 31, 2023 | 28.43% |
| Dec 31, 2022 | 65.56% |
| Sep 30, 2022 | 41.30% |
| Jun 30, 2022 | 25.68% |
| Mar 31, 2022 | 25.49% |
| Dec 31, 2021 | -26.82% |
| Sep 30, 2021 | 5.34% |
| Jun 30, 2021 | -28.31% |
| Mar 31, 2021 | -26.55% |
| Dec 31, 2020 | -174.13% |
| Sep 30, 2020 | -207.68% |
| Jun 30, 2020 | -60.95% |
| Mar 31, 2020 | -48.66% |
| Dec 31, 2019 | 31.73% |
| Sep 30, 2019 | 52.40% |
| Jun 30, 2019 | 42.92% |
| Mar 31, 2019 | 34.59% |
| Dec 31, 2018 | 49.53% |
| Sep 30, 2018 | -83.41% |
| Jun 30, 2018 | -64.32% |
| Mar 31, 2018 | -1,670.81% |
| Dec 31, 2017 | -1,525.66% |
| Sep 30, 2017 | -905.26% |
| Jun 30, 2017 | -1,003.80% |